Influence of CARD15 mutations on disease activity and response to therapy in 65 pediatric Crohn patients from Saxony, Germany

Journal of Pediatric Gastroenterology and Nutrition

Volumn 41, Issue 1, 2005, Pages 27-32

  Roesler, Joachim ^a   Thürigen, Anett ^a   Sun, Liping ^a   Koch, Rainer ^a   Winkler, Ulf ^a   Laass, Martin W ^a   Gahr, Manfred ^a   Rösen Wolff, Angela ^a   Henker, Jobst ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Crohn disease; Genotype phenotype correlation; Genotyping

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CORTICOSTEROID; GENOMIC DNA; GROWTH HORMONE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CROHN DISEASE; DIET SUPPLEMENTATION; DISEASE ACTIVITY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GERMANY; HUMAN; HUMAN TISSUE; LISTERIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TUBE FEEDING; YERSINIA;

ADOLESCENT; BODY HEIGHT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROHN DISEASE; FEMALE; GENOTYPE; GERMANY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX;

EID: 22044434790     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MPG.0000165017.00562.27     Document Type: Article

References (21)

1. Oliva-Hemker M, Fiocchi C. Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective. Inflamm Bowel Dis 2002;8:112-28.
2. Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999;28:445-58.
3. Hugot JP, Alberti C, Berrebi D, Hingen E, Cezard JP. Crohn's disease: the cold chain hypothesis. Lancet 2003;362:2012-5.
4. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
5. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
6. Berrebi D, Maudinas R, Hugot JP, et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003;52:840-6.
7. Jobin C. Intestinal epithelial cells and innate immunity in the intestine: is CARD15/Nod2 another player? Gastroenterology 2003; 124:1145-9.
8. Rosenstiel P, Fantini M, Brautigam K, et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003;124:1001-9.
9. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993-1000.
10. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812-8.
11. Girardin SE, Hugot JP, Sansonetti PJ. Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol 2003;24:652-8.
12. O'Neill LA. How NOD-ing off leads to Crohn disease. Nat Immunol 2004;5:776-8.
13. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004;5:800-8.
14. Armuzzi A, Ahmad T, Ling KL, et al. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 2003;52:1133-9.
15. Uthoff SM, Crawford NP, Eichenberger MR, et al. Association of ulcerative colitis with the inflammatory bowel disease susceptibility locus IBD2 in non-Jewish Caucasians and evidence of genetic heterogeneity among racial and ethnic populations with Crohn disease. Am J Med Genet 2002;113:242-9.
16. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
17. Sun L, Roesler J, Rosen-Wolff A, et al. CARD15 genotype and phenotype analysis in 55 pediatric patients with Crohn disease from Saxony, Germany. J Pediatr Gastroenterol Nutr 2003;37:492-7.
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.
19. Harms HK, Blomer R, Bertele-Harms RM, et al. A paediatric Crohn's disease activity index (PCDAI). Is it useful? Acta Paediatr Suppl 1994;83:22-6.
20. Escher JC, Taminiau JA, Nieuwenhuis EE, Buller HA, Grand RJ. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm Bowel Dis 2003;9:34-58.
21. Tomer G, Ceballos C, Concepcion E, Benkov KJ. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am J Gastroenterol 2003;98:2479-84.